KalVista Pharmaceuticals (KALV) Other Working Capital Changes (2014 - 2025)
KalVista Pharmaceuticals recorded quarterly Other Working Capital Changes of $493000.0 in Q3 2025, down 61.51% quarter-over-quarter from $1.3 million in Q2 2025, and down 37.04% year-over-year from $783000.0 in Q3 2024.
KalVista Pharmaceuticals' Other Working Capital Changes history runs 12 years deep, the most recent figure standing at $493000.0 for Q3 2025.
- In Q3 2025, Other Working Capital Changes fell 37.04% year-over-year to $493000.0; the TTM figure through Jul 2025 stood at $453000.0 (up 42.45% YoY), while the FY2025 annual figure was $1.4 million, up 152.42% from the prior year.
- Other Working Capital Changes came in at $493000.0 for Q3 2025 at KalVista Pharmaceuticals, down from $1.3 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $5.6 million in Q2 2022 to a low of -$2.2 million in Q2 2023.
- A 5-year average of $380888.9 and a median of $559000.0 in 2021 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 1914.7% in 2022 and fell as far as 409.6% in 2022.
- KalVista Pharmaceuticals' Other Working Capital Changes stood at $1.8 million in 2021, then slumped by 195.6% to -$1.7 million in 2022, then slipped by 2.86% to -$1.8 million in 2023, then decreased by 19.27% to -$2.1 million in 2024, then jumped by 123.43% to $493000.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $493000.0, $1.3 million, and -$2.1 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 493,000.00 |
| Jul 31, 2025 | 493,000.00 |
| Apr 30, 2025 | 1.28 Mn |
| Apr 30, 2025 | 1.28 Mn |
| Oct 31, 2024 | -2.10 Mn |
| Oct 31, 2024 | -2.10 Mn |
| Jul 31, 2024 | 783,000.00 |
| Jul 31, 2024 | 783,000.00 |
| Apr 30, 2024 | 1.44 Mn |
| Apr 30, 2024 | 1.44 Mn |
| Jan 31, 2024 | -145,000.00 |
| Jan 31, 2024 | -145,000.00 |
| Oct 31, 2023 | -1.76 Mn |
| Oct 31, 2023 | -1.76 Mn |
| Jul 31, 2023 | 1.00 Mn |
| Jul 31, 2023 | 1.00 Mn |
| Apr 30, 2023 | -2.25 Mn |
| Apr 30, 2023 | -2.25 Mn |
| Jan 31, 2023 | -790,000.00 |
| Jan 31, 2023 | -790,000.00 |
| Oct 31, 2022 | -1.72 Mn |
| Oct 31, 2022 | -1.72 Mn |
| Jul 31, 2022 | -1.94 Mn |
| Jul 31, 2022 | -1.94 Mn |
| Apr 30, 2022 | 5.62 Mn |
| Apr 30, 2022 | 5.62 Mn |
| Jan 31, 2022 | 1.24 Mn |
| Jan 31, 2022 | 1.24 Mn |
| Oct 31, 2021 | 1.79 Mn |
| Oct 31, 2021 | 1.79 Mn |
| Jul 31, 2021 | 625,000.00 |
| Jul 31, 2021 | 625,000.00 |
| Apr 30, 2021 | 279,000.00 |
| Apr 30, 2021 | 279,000.00 |
| Jan 31, 2021 | 3.00 Mn |
| Jan 31, 2021 | 3.00 Mn |
| Oct 31, 2020 | -1.73 Mn |
| Oct 31, 2020 | -1.73 Mn |
| Jul 31, 2020 | -1.30 Mn |
| Jul 31, 2020 | -1.30 Mn |
| Apr 30, 2020 | -12.88 Mn |
| Apr 30, 2020 | -12.88 Mn |
| Jan 31, 2020 | 972,000.00 |
| Jan 31, 2020 | 972,000.00 |
| Oct 31, 2019 | -224,000.00 |
| Oct 31, 2019 | -224,000.00 |
| Jul 31, 2019 | -561,000.00 |
| Jul 31, 2019 | -561,000.00 |
| Apr 30, 2019 | -2.93 Mn |
| Apr 30, 2019 | -2.93 Mn |
| Jan 31, 2019 | -13.72 Mn |
| Jan 31, 2019 | -13.72 Mn |
| Oct 31, 2018 | 448,000.00 |
| Oct 31, 2018 | 448,000.00 |
| Jul 31, 2018 | 69,000.00 |
| Jul 31, 2018 | 69,000.00 |
| Apr 30, 2018 | -33.06 Mn |
| Apr 30, 2018 | -33.06 Mn |
| Jan 31, 2018 | 33.17 Mn |
| Jan 31, 2018 | 33.17 Mn |
| Oct 31, 2017 | 551,000.00 |
| Oct 31, 2017 | 551,000.00 |
| Jul 31, 2017 | 85,000.00 |
| Jul 31, 2017 | 85,000.00 |
| Apr 30, 2017 | -608,000.00 |
| Apr 30, 2017 | -608,000.00 |
| Jan 31, 2017 | 961,000.00 |
| Jan 31, 2017 | 961,000.00 |
| Oct 31, 2016 | -358,000.00 |
| Oct 31, 2016 | -358,000.00 |
| Jul 31, 2016 | 86,000.00 |
| Jul 31, 2016 | 86,000.00 |
| Mar 31, 2016 | -85,000.00 |
| Mar 31, 2016 | -85,000.00 |
| Dec 31, 2015 | -349,000.00 |
| Dec 31, 2015 | -349,000.00 |
| Sep 30, 2015 | 895,000.00 |
| Sep 30, 2015 | 895,000.00 |
| Jun 30, 2015 | -451,000.00 |
| Jun 30, 2015 | -451,000.00 |
| Mar 31, 2015 | 437,000.00 |
| Mar 31, 2015 | 437,000.00 |
| Sep 30, 2014 | 45,000.00 |
| Sep 30, 2014 | 45,000.00 |
| Jun 30, 2014 | -79,000.00 |
| Jun 30, 2014 | -79,000.00 |
| Mar 31, 2014 | 68,000.00 |
| Mar 31, 2014 | 68,000.00 |